Oxabolone: Drug History, Cypionate Ester and Health Risks

Oxabolone is a synthetic anabolic androgenic steroid also called 4 hydroxy 19 nortestosterone. Oxabolone cypionate, also spelled cipionate, is its ester form and appeared under historical.

On this page

Oxabolone is a synthetic anabolic androgenic steroid also called 4 hydroxy 19 nortestosterone. Oxabolone cypionate, also spelled cipionate, is its ester form and appeared under historical Steranabol names. Human evidence is very limited. Chemical, legal and laboratory records do not establish a current treatment role, a safe nonmedical amount or a predictable physique result.

Evidence boundary: chemical records can identify a reference substance. Historical medicine records can show earlier names and uses. Neither source type proves present approval, product purity, personal benefit, personal risk or a safe exposure.

Sources checked 2 September 2026. This page gives general information. It does not provide a diagnosis, prescription, exposure plan, product source, administration method or drug testing advice.

What is oxabolone?

Oxabolone is the parent steroid known as 4 hydroxy 19 nortestosterone. PubChem records the molecular formula C18H26O3, compound identifier 20055236 and CAS registry number 4721 69 1.[1] The name describes one molecule, not every product that uses the word oxabolone.

The 19 nor name reflects the missing carbon 19 methyl group. The 4 hydroxy name identifies a hydroxyl group at carbon 4. These features place oxabolone near nandrolone while preserving a separate identity.

Oxabolone is not oxandrolone. Similar names do not transfer chemistry, medicine history or research findings from one drug to the other.

Oxabolone identity card
Primary name Oxabolone
Parent chemical description 4 hydroxy 19 nortestosterone
Parent formula C18H26O3
Parent PubChem identifier 20055236
Named ester Oxabolone cypionate, also written oxabolone cipionate
Historical names FI 5852, Steranabol Ritardo and Steranabol Depot
Drug class Anabolic androgenic steroid and androgen receptor agonist
Direct human outcome evidence Sparse. The reviewed human paper focused on metabolism and laboratory detection, not treatment results or long term safety.

What is oxabolone cypionate?

Oxabolone cypionate is an ester of the oxabolone parent. PubChem records formula C26H38O4 and compound identifier 68952.[2] KEGG records the name oxabolone cipionate as a Japanese Accepted Name and International Nonproprietary Name, with CAS number 1254 35 9.[3]

Cipionate and cypionate are spelling variants for the same ester in these records. The side chain changes formulation and release before enzymes free the parent steroid. It does not remove androgen activity.

The archived poison monograph lists FI 5852, Steranabol Ritardo and Steranabol Depot.[4] These are historical entries, not proof of a present licensed or genuine product.

Parent drug and ester form
Attribute Oxabolone Oxabolone cypionate
Chemical role Parent active steroid Ester form that can release the parent steroid
Formula C18H26O3 C26H38O4
Common record names 4 hydroxy 19 nortestosterone Oxabolone cypionate, oxabolone cipionate, FI 5852
Historical product names No verified product identity follows from the parent name alone Steranabol Ritardo and Steranabol Depot in archived records
What the form can change Reference identity of the active molecule Formulation, absorption pattern and release before ester cleavage
What the form cannot prove Current approval, product contents, a safe nonmedical exposure, personal benefit or a lower personal risk

How is oxabolone different from oxandrolone and nandrolone?

Oxabolone is a 4 hydroxy derivative of 19 nortestosterone. Nandrolone is 19 nortestosterone without that carbon 4 hydroxyl group. Oxandrolone is a separate steroid with a different ring structure and a different medical history. Similar letters at the start of two names do not create a chemical synonym.

This distinction stops evidence from moving to the wrong drug. A nandrolone label cannot define oxabolone cypionate. An oxandrolone burn study cannot establish an oxabolone benefit. A chemical record cannot authenticate a product.

Related names that should not be merged
Entity Relationship Evidence boundary
Oxabolone 4 hydroxy 19 nortestosterone parent steroid Owns the identity, historical record and health evidence discussed on this page
Oxabolone cypionate Cypionate ester of oxabolone Historical ester records do not prove a current licensed product
Oxandrolone Separate anabolic steroid with different chemistry Oxandrolone research stays with the oxandrolone topic
Nandrolone Closest parent family relationship Nandrolone formulations and outcomes cannot be assigned to oxabolone
Nandrolone phenylpropionate Different ester of nandrolone An ester comparison requires evidence for each named compound and form

How may oxabolone act in the body?

KEGG classifies oxabolone cipionate as an androgen receptor agonist and an anabolic steroid.[3] The archived monograph explains the wider class mechanism: anabolic steroids bind androgen receptors in reproductive tissue, muscle and fat. The same class can produce tissue building and virilizing effects.[4]

A depot formulation releases an ester before cleavage frees the parent steroid. The archived monograph describes slower absorption for lipid soluble cypionate esters.[4] This explains formulation, not an administration plan.

Androgen activity can produce wanted and unwanted effects through related pathways. External exposure can suppress pituitary signals, natural gonadal hormone production and sperm formation. Oxabolone specific rates remain unknown.

What mechanism records can and cannot answer
Record Supported point Point still unresolved
Androgen receptor classification Oxabolone cypionate belongs to an androgen active steroid class Size of a human physique or performance effect
Ester chemistry The cypionate side chain changes formulation before the parent is released A precise release pattern for an unknown product
Class endocrine action External androgens can suppress reproductive hormone signals Personal recovery time or fertility outcome
Structural similarity Oxabolone has a relationship to nandrolone Permission to copy a nandrolone label, dose or risk rate

Was oxabolone used as a medicine?

Historical authority records associate oxabolone cypionate with Steranabol products. The NCATS substance summary also records former use for osteoporosis.[6] These records support a past medicine context, not a present prescription claim.

The archived monograph grouped oxabolone cypionate with systemic anabolic agents. It supplied no direct adult or child toxicity data for this drug. It is a history and toxicology source, not a current product label.

The FDA Global Substance Registration System contains an oxabolone identity entry.[13] A substance entry is not a medicine approval. The checked sources supplied no current US label.

How to read oxabolone status records
Record type What it shows What it does not show
PubChem or GSRS substance entry A named chemical identity and identifiers A current treatment indication or approved product
NCATS summary A historical statement about osteoporosis use Current licensing in every country
Archived poison monograph Older names, class context, chemistry and general toxicology A present label, current availability or direct modern safety rate
Controlled drug rule Legal control within the named jurisdiction Medicine approval, quality or suitability
Sport prohibited list Eligibility rule for covered sport Criminal law or a clinical recommendation

What human research exists for oxabolone?

The clearest direct human paper in the reviewed source set is a 1995 metabolism study. Researchers gave oxabolone cypionate to volunteers and used gas chromatography with mass spectrometry to study urinary excretion. They identified the parent compound and five metabolites.[5]

That paper answers an analytical question. It reports no treatment benefit, athletic result, safe exposure or long term adverse event rate. Its detection observations cannot predict a personal test result across different products, samples, methods and people.

The archived monograph reported no direct adult or child toxicity data for oxabolone.[4] Newer chemical databases add identity detail, not human outcomes.

Direct and indirect oxabolone evidence
Evidence source Main question Useful finding Main limit
1995 volunteer metabolism paper Which urinary compounds follow controlled exposure? Parent oxabolone cypionate and five metabolites were identified Not a treatment, physique, performance or safety trial
Archived poison monograph What historical identity and toxicology context was recorded? Names, formula, class, general mechanism and class concerns Old record with no direct adult or child oxabolone toxicity dataset
PubChem, KEGG and GSRS What substance is being named? Formula, identifiers, ester relationship and receptor classification No human outcome estimate or product authentication
Anabolic steroid class research Which harms are biologically and clinically plausible? Cardiovascular, endocrine, psychiatric, liver, kidney, infectious and musculoskeletal concern Cannot assign an oxabolone specific event rate

How strong is the evidence for common oxabolone claims?

Claim level evidence matrix
Claim Best source type Confidence Reason
Oxabolone is 4 hydroxy 19 nortestosterone Chemical identity databases and legal text High Several authority records describe the same parent structure
Oxabolone cypionate is the ester form PubChem, KEGG and archived medicine records High for reference identity The ester formula and parent relationship agree across records
Steranabol was a historical product name Archived poison information record Moderate to high for history The old record names Steranabol Ritardo and Steranabol Depot
Oxabolone has a current approved human indication Current medicine regulator and product label Not established by the checked sources The sources support identity and history, not a current human label
Oxabolone produces a predictable muscle or strength result Controlled human outcome trials Not established The direct human paper studied metabolism, not performance
One ester form is safe for nonmedical use Controlled comparative human safety research Not established No reviewed source defines a safe nonmedical amount or safer ester
An unknown product contains oxabolone Suitable laboratory analysis of the exact sample Unknown without testing A name, colour, seller statement or package cannot prove contents

What health risks are linked to oxabolone?

No current human oxabolone label supplies reliable adverse effect rates. Wider anabolic steroid evidence covers cardiovascular, psychiatric, metabolic, endocrine, neurologic, infectious, liver, kidney and musculoskeletal disorders.[11]

Class evidence supports concern, but it cannot predict one person’s outcome or isolate oxabolone from other substances. Product identity, health history and other exposures can change the picture.

Health areas that may need attention
Health area Anabolic steroid class concern Oxabolone evidence limit
Heart, vessels and blood Adverse cholesterol, raised blood pressure, blood count changes, heart disease, clot and stroke concern No reliable oxabolone event rate
Hormones and fertility Suppressed natural hormone signals, reduced sperm production, sexual changes and fertility problems No personal recovery forecast
Women and pregnancy Voice change, hair growth, menstrual change, clitoral enlargement and fetal virilization concern Some virilizing changes may persist, but oxabolone specific rates are unknown
Liver and kidneys Abnormal liver tests, liver injury and kidney stress through several direct or indirect paths The ester route does not prove absence of organ risk
Mood, sleep and dependence Irritability, anxiety, aggression, depression, sleep disturbance, withdrawal symptoms and dependence No compound specific probability
Skin, hair and tendons Acne, scalp hair loss, increased body hair and tendon injury concern Symptoms have many possible causes
Injected product harms Abscess, tissue injury, blood borne infection, particulates and contamination Risk depends on the product and exposure conditions, not the hormone alone

Read the anabolic steroid health risk overview for the wider evidence by body system. The urgent warning signs page explains when symptoms need emergency action.

Which interactions and health settings may raise concern?

The archived oxabolone monograph reports no direct interaction data.[4] This gap does not prove compatibility with medicines, supplements or other drugs. Several exposures can affect the same organ system and make a symptom or laboratory change harder to explain.

Tell a clinician about every claimed steroid, ester, medicine, supplement, stimulant, alcohol exposure and recreational drug. Add dates, routes and symptoms. Do not change prescribed medicine solely to alter a result without clinical advice.

Prompt professional input points with heart or vascular disease, high blood pressure, liver or kidney disease, sleep apnea or a clot history. Fertility plans, pregnancy, severe mental illness, dependence, infection and adolescent growth also change the care context.

A single normal test cannot clear every risk. A single abnormal test also cannot prove oxabolone caused the change. Timing, recent exercise, hydration, illness, laboratory method and previous results all matter.

What may a clinician assess after possible oxabolone exposure?

A useful clinical record starts with the exact claimed name and form. Add exposure dates, route, other substances, symptoms and earlier results. A label photograph shows what was claimed, not what the product contained.

Assessment follows the history, examination and main concern. It may cover blood pressure, blood count, cholesterol, liver, kidneys, hormones, fertility, heart, mental health or a painful injection area. Not every person needs every test.

Each test should answer a clinical question. A blood count and an electrocardiogram address different concerns. Neither test certifies ongoing exposure as safe.

See how to talk with a doctor about anabolic steroid use and what blood tests can and cannot show.

What is the legal and sport status of oxabolone?

Legal control, medicine approval and sport eligibility answer different questions. A controlled drug listing does not prove current medicine approval. Sport rules can also differ from national law.

Current legal and sport records checked for oxabolone
System Record Scope
United States federal law Current Schedule III text lists 4 hydroxy 19 nortestosterone and covers its salts, esters and ethers.[7] Federal control does not settle state law, medicine approval, product identity or facts of a specific case.
United Kingdom The Home Office list records oxabolone as Class C and Schedule 4 Part 2.[8] Possession, supply and import rules differ. Current legal advice may be needed for a real case.
Competitive sport The 2026 World Anti Doping Agency list names oxabolone in category S1 among anabolic agents prohibited at all times.[9] The rule applies within covered sport. Athletes should check the current list and governing body process.

No detection window, masking method, sample manipulation method or rule avoidance advice appears on this page.

Can a label prove that a product contains oxabolone?

No. A label, colour, package, seller statement or price cannot confirm chemical identity, amount, sterility or batch consistency. A historical Steranabol name does not authenticate a present vial.

Chemical databases describe reference substances, not a product held by a reader. Laboratory analysis addresses only the sample and method used. Another batch can differ.

After a suspected exposure, record the claimed name, dates, route, other substances and symptoms. Keep packaging when safe and share the record with a clinician or poison service. Severe symptoms need emergency care.

References

  1. Oxabolone compound record. PubChem, National Library of Medicine. Parent identity, formula and identifiers.
  2. Oxabolone cipionate compound record. PubChem, National Library of Medicine. Ester identity, formula and parent relationship.
  3. KEGG drug record D01149. KEGG. Accepted name, class, androgen receptor target and identifiers.
  4. Oxabolone cipionate poison information monograph 912. International Programme on Chemical Safety. Historical names, chemistry, class pharmacology and evidence gaps.
  5. Metabolism and excretion of oxabolone in humans. Journal of High Resolution Chromatography. 1995.
  6. Oxabolone substance record. National Center for Advancing Translational Sciences. Historical osteoporosis statement and substance identity.
  7. Title 21 CFR 1308.13. Electronic Code of Federal Regulations. Current United States Schedule III text.
  8. United Kingdom controlled drugs list. Home Office. Current class and schedule entry.
  9. World Anti Doping Agency 2026 Prohibited List. Current sport rule for anabolic agents.
  10. Steroids fact sheet. United States Drug Enforcement Administration. Anabolic steroid class and health context.
  11. Adverse health consequences of performance drugs. Endocrine Society scientific statement.
  12. Diagnosis and management of anabolic androgenic steroid use. Journal of Clinical Endocrinology and Metabolism. 2019.
  13. Oxabolone substance record. FDA Global Substance Registration System. Substance identity record.